Anavex Life Sciences Corp.

Anavex Life Sciences Corp. is a Profit Corporation in Carson City, United States with 2 ISIN-identified securities mapped to its LEI, which is how regulators tie a traded instrument to the issuer behind it.

The LEI has been on record for 11 years, since 11 Jul 2015. That is about 3 years earlier than the median LEI in United States, which dates from 2019 — an early adopter by local standards.

The next annual re-validation is due 12 Aug 2027, 332 days from now.

This archive holds 2 versions of the record. The most recent change was on 15 Jul 2026 and altered the next renewal; the oldest version we hold dates from 6 Jul 2026. GLEIF publishes only the current state, so superseded values are not available from the source.

The LEI is issued and maintained by Bloomberg Finance L.P., one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 2 ISINs are mapped to this entity in the GLEIF cross-reference files.

No direct accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is issued, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.